Citation Impact
Citing Papers
Extensive Intrasubtype Recombination in South African Human Immunodeficiency Virus Type 1 Subtype C Infections
2007
HIV rebounds from latently infected cells, rather than from continuing low-level replication
2008
Short DNA Hairpins Compromise Recombinant Adeno-Associated Virus Genome Homogeneity
2017
Down-Regulation of Na+/K+ATPase Activity by Human Parvovirus B19 Capsid Protein VP1
2013 Standout
Circular Intermediates of Recombinant Adeno-Associated Virus Have Defined Structural Characteristics Responsible for Long-Term Episomal Persistence in Muscle Tissue
1998
Adeno-associated virus vectors
1992
HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case–cohort analysis
2008
X4 and R5 HIV-1 Have Distinct Post-entry Requirements for Uracil DNA Glycosylase during Infection of Primary Cells
2010 StandoutNobel
Nuclear landscape of HIV-1 infection and integration
2016
Cell Lines for the Production of Recombinant Adeno-Associated Virus
1995
Development and Optimization of a Real-Time Quantitative PCR-Based Method for the Titration of AAV-2 Vector Stocks
2002
Molecular imaging in living subjects: seeing fundamental biological processes in a new light
2003 Standout
R5 to X4 Switch of the Predominant HIV-1 Population in Cellular Reservoirs During Effective Highly Active Antiretroviral Therapy
2005
Syndemics and the biosocial conception of health
2017 Standout
Inflammation and Cancer: Triggers, Mechanisms, and Consequences
2019 Standout
AAV Capsid Structure and Cell Interactions
2011
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
HIV persists throughout deep tissues with repopulation from multiple anatomical sources
2020
In Utero Delivery of Adeno-Associated Viral Vectors: Intraperitoneal Gene Transfer Produces Long-Term Expression
2001
Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain
1994
Biology of Adeno-associated Virus
1996
Periluminal Distribution of HIV-Binding Target Cells and Gp340 in the Oral, Cervical and Sigmoid/Rectal Mucosae: A Mapping Study
2015 StandoutNobel
Human gene targeting by viral vectors
1998
Co‐expression of C‐terminal truncated alpha‐synuclein enhances full‐length alpha‐synuclein‐induced pathology
2010
Design and development of polymers for gene delivery
2005 Standout
Single-spike detection in vitro and in vivo with a genetic Ca2+ sensor
2008 StandoutNobel
Coreceptors and HIV-1 Pathogenesis
2010
[48] Production and purification of recombinant adeno-associated virus
2000
Adeno-associated virus: integration at a specific chromosomal locus
1993
Induction of peripheral CD8+ T‐cell tolerance by cross‐presentation of self antigens
1998 StandoutNobel
Differential and persistent expression patterns of CNS gene transfer by an adeno-associated virus (AAV) vector
1996
Papillomaviruses and cancer: from basic studies to clinical application
2002 StandoutNobel
Progress in Adeno-Associated Virus Type 2 Vector Production: Promises and Prospects for Clinical Use
1999
Promise and problems associated with the use of recombinant AAV for the delivery of anti-HIV antibodies
2016
Priming of hepatitis C virus-specific cytotoxic t lymphocytes in mice following portal vein injection of a liver-specific plasmid DNA
2000 StandoutNobel
In vivo genome editing using Staphylococcus aureus Cas9
2015 StandoutNature
Distinct Neuronal Coding Schemes in Memory Revealed by Selective Erasure of Fast Synchronous Synaptic Transmission
2012 StandoutNobel
Factors Influencing Recombinant Adeno-Associated Virus Production
1998
Organization of adeno-associated virus DNA in latently infected detroit 6 cells
1989
An amino-acid taste receptor
2002 StandoutNature
Adeno-associated virus and the development of adeno-associated virus vectors: a historical perspective
2004
Enhanced Expression of Transgenes from Adeno-Associated Virus Vectors with the Woodchuck Hepatitis Virus Posttranscriptional Regulatory Element: Implications for Gene Therapy
1999
Progress and problems with the use of viral vectors for gene therapy
2003 Standout
Recombinant adeno-associated virus for muscle directed gene therapy
1997
Adeno-associated virus vector as a platform for gene therapy delivery
2019 Standout
Molecular, cellular and clinical aspects of Parvovirus B19 infection
1994
Persistence of distinct HIV-1 populations in blood monocytes and naive and memory CD4 T cells during prolonged suppressive HAART
2005
Cystic fibrosis: molecular biology and therapeutic implications
1992 StandoutScience
Retroviral vectors displaying functional antibody fragments
1993 StandoutNobel
Antiretroviral Drug Resistance Testing in Adult HIV‐1 Infection: 2008 Recommendations of an International AIDS Society–USA Panel
2008
Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield
1999 Standout
Subventricular Zone Astrocytes Are Neural Stem Cells in the Adult Mammalian Brain
1999 Standout
Transfer of Contaminants in Adeno-Associated Virus Vector Stocks Can Mimic Transduction and Lead to Artifactual Results
1997
Transient Immunosuppression Allows Transgene Expression Following Readministration of Adeno-Associated Viral Vectors
1998
Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial
2008 Standout
Systematic Mutagenesis of α-Synuclein Reveals Distinct Sequence Requirements for Physiological and Pathological Activities
2012 StandoutNobel
HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation
2009 Standout
Use of Adeno-Associated Virus as a General Transduction Vector for Mammalian Cells
1992
Structural Analysis of Adeno-Associated Virus Transduction Circular Intermediates
1999
Antiretroviral Treatment of Adult HIV Infection
2012 Standout
Quantitative Deep Sequencing Reveals Dynamic HIV-1 Escape and Large Population Shifts during CCR5 Antagonist Therapy In Vivo
2009
Optogenetics in Neural Systems
2011 Standout
Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors
1997
Fluorescent indicators for Ca2+based on green fluorescent proteins and calmodulin
1997 StandoutNatureNobel
Gene therapy restores vision in a canine model of childhood blindness
2001 Standout
Parkinson's Disease
2003 Standout
Overcoming adeno-associated virus vector size limitation through viral DNA heterodimerization
2000
Prospects for the Use of Adeno-Associated Virus as a Vector for Human Gene Therapy
1994
Long-Term Control of HIV by CCR5 Delta32/Delta32 Stem-Cell Transplantation
2009 Standout
Gene Therapy for X-Linked Severe Combined Immunodeficiency: Where Do We Stand?
2016
S/MAR Element Facilitates Episomal Long-Term Persistence of Adeno-Associated Virus Vector Genomes in Proliferating Cells
2017
Large-Scale Adeno-Associated Viral Vector Production Using a Herpesvirus-Based System Enables Manufacturing for Clinical Studies
2009
Quantitative Analysis of the Packaging Capacity of Recombinant Adeno-Associated Virus
1996
Adeno-associated virus sensitizes HeLa cell tumors to gamma rays
1992 StandoutNobel
RSeQC: quality control of RNA-seq experiments
2012 Standout
Dual-target Inhibition of HIV-1 in Vitro by Means of an Adeno-Associated Virus Antisense Vector
1992 Science
Parkinson-Like Neurodegeneration Induced by Targeted Overexpression of α-Synuclein in the Nigrostriatal System
2002
Factors that bind to adeno-associated virus terminal repeats
1989
Isolation of Recombinant Adeno-Associated Virus Vector-Cellular DNA Junctions from Mouse Liver
1999
THE GREEN FLUORESCENT PROTEIN
1998 StandoutNobel
Human Adeno-Associated Virus Type 5 Is Only Distantly Related to Other Known Primate Helper-Dependent Parvoviruses
1999 StandoutNobel
Production of Recombinant Adeno‐Associated Viral Vectors
1999
HIV Transmission
2012
Direct Gene Transfer into Mouse Muscle in Vivo
1990 StandoutScience
Production of High-Titer Recombinant Adeno-Associated Virus Vectors in the Absence of Helper Adenovirus
1998
Genomes in Focus: Development and Applications of CRISPR‐Cas9 Imaging Technologies
2017 StandoutNobel
Transduction with recombinant adeno-associated virus for gene therapy is limited by leading-strand synthesis
1996
DNA-damaging agents greatly increase the transduction of nondividing cells by adeno-associated virus vectors
1994
Site-specific integration by adeno-associated virus.
1990
Population-Based Sequencing of the V3 Region of env for Predicting the Coreceptor Usage of Human Immunodeficiency Virus Type 1 Quasispecies
2007 StandoutNobel
Naive T-Cell Depletion Related to Infection by X4 Human Immunodeficiency Virus Type 1 in Poor Immunological Responders to Highly Active Antiretroviral Therapy
2006 StandoutNobel
Production of Recombinant Adeno‐Associated Viral Vectors
2007
Adeno-Associated Virus Structural Biology as a Tool in Vector Development
2013
Characterization of Adeno-Associated Virus Genomes Isolated from Human Tissues
2005
Helper-free stocks of recombinant adeno-associated viruses: normal integration does not require viral gene expression
1989
A Field Guide to Foldamers
2001 Standout
Adeno-associated virus vectors preferentially transduce cells in S phase.
1994
Adeno-associated virus as a gene delivery system
1997
Progress Toward Human Gene Therapy
1989 Science
Induction of differentiation-associated changes in established human cells by infection with adeno-associated virus type 2
1992 StandoutNobel
Response of Hepatitis C Virus to Long-Term Passage in the Presence of Alpha Interferon: Multiple Mutations and a Common Phenotype
2013 StandoutNobel
A "humanized" green fluorescent protein cDNA adapted for high-level expression in mammalian cells
1996
Viral Vectors for Gene Therapy: Translational and Clinical Outlook
2015
Increased Replicative Fitness Can Lead to Decreased Drug Sensitivity of Hepatitis C Virus
2014 StandoutNobel
In vivo hematopoietic stem cell modification by mRNA delivery
2023 StandoutScienceNobel
Human Immunodeficiency Virus Type 1 Coreceptor Switching: V1/V2 Gain-of-Fitness Mutations Compensate for V3 Loss-of-Fitness Mutations
2005
Sequence requirements for binding of Rep68 to the adeno-associated virus terminal repeats
1996
Emerging Targets in Photopharmacology
2016 StandoutNobel
The adeno-associated virus rep gene suppresses herpes simplex virus-induced DNA amplification
1990 StandoutNobel
Targeted gene knock-in by homology-directed genome editing using Cas9 ribonucleoprotein and AAV donor delivery
2017 StandoutNobel
Improving HIV coreceptor usage prediction in the clinic using hints from next-generation sequencing data
2012
HIV-1 coreceptor preference is distinct from target cell tropism: a dual-parameter nomenclature to define viral phenotypes
2006
Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector
1996
Parkinson-like neurodegeneration induced by targeted overexpression of alpha-synuclein in the nigrostriatal system.
2002
Internal Disequilibria and Phenotypic Diversification during Replication of Hepatitis C Virus in a Noncoevolving Cellular Environment
2017 StandoutNobel
Efficient photoreceptor-targeted gene expression in vivo by recombinant adeno-associated virus
1997
Targeted integration of adeno-associated virus (AAV) into human chromosome 19.
1991
Adeno-associated viruses undergo substantial evolution in primates during natural infections
2003
Recruitment of Single-Stranded Recombinant Adeno-Associated Virus Vector Genomes and Intermolecular Recombination Are Responsible for Stable Transduction of Liver In Vivo
2000
Dynamic and quantitative Ca 2+ measurements using improved cameleons
1999 StandoutNobel
Perturbation of the cell cycle by adeno-associated virus
1988
Infection of primary cells by adeno-associated virus type 2 results in a modulation of cell cycle-regulating proteins
1997 StandoutNobel
Works of Sherry McLaughlin being referenced
Proliferation of cells with HIV integrated into cancer genes contributes to persistent infection
2014 Science
Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes
2006
Improved Coreceptor Usage Prediction and GenotypicMonitoring of R5-to-X4 Transition by Motif Analysis of HumanImmunodeficiency Virus Type 1 env V3 LoopSequences
2003
Evolution of CCR5 Use before and during Coreceptor Switching
2008
Selection on the Human Immunodeficiency Virus Type 1 Proteome following Primary Infection
2006
Adeno-associated virus general transduction vectors: analysis of proviral structures
1988